retatrutide developer eli lilly announces more next-gen obesity drug data, plans Q1 2027 FDA application Who Makes Retatrutide? Company Behind

Curr Opin Endocrinol Diabetes Obes (2013) 20(2):8797

Understanding the causes and implementing targeted management approaches can help you maintain your treatment goals whilst minimising discomfort

A narrative review of 10 primary studies that assessed energy intakes in GLP-1 RA users revealed that total calorie intake was reduced by 16 to 39% in a single meal 25

Fertility, PCOS & Reproductive Health Escobar-Morreale, H

A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome

Long delays, missing updates, and unresponsive support teams show up regularly in low-star reviews